New cutting edge technology can be used to grade cancer tumours, eradicating human subjectivity and ensuring patients get the right treatment.
A new imaging technology to grade tumour biopsies has been developed by a team of scientists led by the Department of Physics and the Department of Surgery and Cancer at Imperial College London.
Publishing their results today in the journal Convergent Science Physical Oncology, they describe how their new method promises to significantly reduce the subjectivity and variability in grading the severity of cancers.
[Digistain] is an extremely reliable indicator of the degree of progression of the disease. Because it is based on a physical measurement, rather than a human judgement, it promises to remove the element of chance in cancer diagnosis.Professor Chris Phillips
Nearly all cancers are still diagnosed by doctors taking a sample of the tumour, a so-called biopsy, then slicing it thinly and staining it with two vegetable dyes used for more than 100 years. They look at this ‘H+E stained’ sample under a microscope and then judge the severity of the disease by eye alone.
Life-changing treatment decisions have to be based on this ‘grading’ process, yet it is well known that different practitioners given the same slice will only agree on its grade about 70% of the time, resulting in an overtreatment problem.
The team’s new ‘Digistain’ technology addresses this problem by using invisible mid-infrared light to photograph the tissue slices in a way that maps out the chemical changes that signal the onset of cancer. In particular, they measure the ‘nuclear-to-cytoplasmic-ratio’ (NCR): a recognized biological marker for a wide range of cancers.
Lead author Professor Chris Phillips, from the Department of Physics at Imperial, said: “Our machine gives a quantitative ‘Digistain index’ (DI) score, corresponding to the NCR, and this study shows that it is an extremely reliable indicator of the degree of progression of the disease. Because it is based on a physical measurement, rather than a human judgement, it promises to remove the element of chance in cancer diagnosis. “
In the experiment reported today, the team carried out a double-blind clinical pilot trial using two adjacent slices taken from 75 breast cancer biopsies. The first slice was graded by clinicians as usual, using the standard H+E protocol. It was also used to identify the so-called ‘region of interest’ (RoI), i.e. the part of the slice containing the tumour.
The team then used the Digistain imager to get a DI value averaged over the corresponding RoI on the other, unstained slice, and ran a statistical analysis on the results.
Professor Phillips said: “Even with this modest number of samples, the correlation we saw between the DI score and the H+E grade would only happen by chance 1 time in 1400 trials. The strength of this correlation makes us extremely optimistic that Digistain will be able to eliminate subjectivity and variability in biopsy grading.”
Proving its worth
The NCR factor that Digistain measures is known to be common to a wide range of cancers, as it occurs when the reproductive cell cycle gets disrupted in the tumour and cell nuclei get distorted with rogue DNA. It is likely that in the long run, Digistain could help with the diagnosis of all different types of cancer.
At a practical level, the researchers say that the Digistain imaging technology can easily and cheaply be incorporated into existing hospital labs, and be used by their staff. Professor Philips added: “It’s easy to prove its worth by checking it with the thousands of existing biopsy specimens that are already held in hospital archives. Together these facts will smooth the path into the clinic, and it could be saving lives in only a couple of years.”
The Latest on: Cancer diagnosis
via Google News
The Latest on: Cancer diagnosis
Researchers identified a protein associated with breast cancer
on April 18, 2018 at 11:59 am
Approximately 250,000 women were diagnosed with breast cancer in 2017, according to National Institutes of Health figures, and about 40,000 died of the disease. Metastatic breast cancer is cancer that has spread to other sites in the body, and the vast ... […]
Polypharmacy more likely for cancer survivors
on April 18, 2018 at 11:40 am
a higher percentage of cancer survivors were prescribed five or more unique medications (64 versus 51.5 percent), including drugs with abuse potential. Compared with controls, a higher percentage of newly (one year or less since diagnosis) and previously ... […]
Diagnosed with ovarian cancer a year apart, friends walk for research funds
on April 18, 2018 at 11:11 am
Brooke Nicklas and Michelle McGee first became friends when their sons were in first grade together. They couldn't have guessed the uncanny parallels their lives would take nearly 15 years later, including an ovarian cancer diagnosis barely a year apart. […]
A woman says she was fat-shamed by doctors who ignored her symptoms — and it turned out she had cancer
on April 18, 2018 at 10:47 am
In an interview with Cosmopolitan, Rebecca Hiles said that doctors ignored her cancer symptoms for years because of her weight. Eventually, her left lung became black and rotten and had to be removed. Hiles's story exemplifies a larger issue: Many women ... […]
Researchers evaluate accuracy of simple blood test to predict lung cancer
on April 18, 2018 at 10:23 am
it's likely not cancer. The biomarker can offer the provider confidence in a diagnosis and treatment plan. "It serves as a 'rule out' test for those with low-to-moderate risk," says Silvestri. "The biomarker is a tool to help calculate the general risk of ... […]
Fat people aren't shocked a doctor diagnosed a woman with cancer as 'just fat'
on April 18, 2018 at 9:46 am
It's a sad and very serious reality: Fat people just aren't treated the same in the doctor's office as everyone else. Doctors regularly misdiagnose serious health issues, attributing every issue a bigger person has to just "weight." Unfortunately, health ... […]
Marcus Smart Reveals Mother’s Cancer Diagnosis, Request For Son In Playoffs
on April 18, 2018 at 7:21 am
Marcus Smart has a very good reason to expedite his rehab process.The Boston Celtics guard revealed Tuesday his 63-year-old mother, Camellia, has been diagnosed with myelodysplastic syndrome, a form of bone marrow cancer. Smart’s mother told her son of ... […]
Biosensors for bladder cancer diagnosis
on April 17, 2018 at 6:31 am
Cancer constitutes one of the leading causes of mortality worldwide. As early diagnosis is paramount to improved clinical outcome and survival, sensitive diagnostics capable of detecting cancer-related molecules are necessary. Despite technological ... […]
Kevin Austin: Former Swansea City defender diagnosed with cancer
on April 17, 2018 at 6:07 am
Kevin Austin made more than 100 appearances for the Swans after joining them from Bristol Rovers in 2004 Former Swansea City defender Kevin Austin has been diagnosed with cancer - but dismissed social media reports the illness was terminal. The 45-year-old ... […]
via Bing News